Syed Nazeer Mahmood

Dr. Syed Nazeer Mahmood

orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 April 2021 in Expert Opinion on Pharmacotherapy
Verified
Journal Article
Closed access
SMSyed Nazeer Mahmood
Syed Nazeer Mahmood
ASAndrew F. Shorr
Andrew F. Shorr
Introduction Ventilator-associated pneumonia (VAP) and hospital-acquired pneumonia (HAP) result in significant morbidity and mortality. The emergence of multi-drug resistant organisms has complicated the matter, as many of these pathogens now represent key causes of VAP and HAP. While a number of new medications have been approved, a comprehensive appreciation of pharmacokinetic and pharmacodynamic principles, which, are often neglected, is key to effective treatment. Areas covered The authors discuss the central pharmacokinetic and pharmacodynamic principles underlying antibiotic utilization, especially as they pertain to the treatment of VAP and HAP. They further address the concept of and implications of augmented renal clearance for the patient with nosocomial pneumonia. Finally, the authors review the evolving data on colistin and inhaled antibiotics in the management of pneumonia. Expert opinion An enhanced understanding of the pharmacokinetic and pharmacodynamic principles along with insight into the concept of augmented renal clearance can help guide drug development and improve the way we currently dose and deliver most antibiotics. There is now mounting data on the limited efficacy and substantial nephrotoxicity of colistin which makes it difficult to justify its continued use. While the concept of inhaled antibiotics is enticing, we lack conclusive data proving efficacy of this paradigm.

1 February 2016 in Annals of Clinical Psychiatry
Verified
Journal Article
Closed access
MBMeenakshi Bamalwa
Meenakshi Bamalwa
SMSyed Nazeer Mahmood
Syed Nazeer Mahmood
SPSamir Kumar Praharaj
Samir Kumar Praharaj
Background: The objectives of this study were to assess the incidence, course, and duration of delirium in patients admitted in the cardiac intensive care unit (ICU) and to outline risk factors associated with the occurrence of delirium. Method: Fifty consecutive patients admitted to a cardiac ICU were screened for the presence of delirium using Confusion Assessment Method prospectively. The risk factors associated with delirium were studied using a semi-structured form. Results: Eight (16%) patients developed delirium during their stay in the cardiac ICU. The mean duration of delirium was 1.5 (SD 0.53) days. The mean days for onset of delirium were 1.63 (SD 0.74), and mean days until delirium resolved were 3.12 (SD 0.83). Fewer years of formal education and electrolyte derangement were associated with the risk of delirium ( P < .05); electrolyte abnormalities accounted for 16.5% of the variance in delirium in our sample. Conclusions: One-sixth of the patients admitted to the cardiac ICU had delirium; lower education and disturbed electrolytes were risk factors for delirium.

13 January 2021 in TH Open
Verified
Journal Article
Open access
PDF file
SMSyed Nazeer Mahmood
Syed Nazeer Mahmood
YDYaser T. Dawod
Yaser T. Dawod
CCChee Man Chan
Chee Man Chan
Thrombotic events have been reported in patients with coronavirus disease 2019 (COVID-19). Pregnant and postpartum patients are also known to be hypercoagulable and those with COVID-19 may therefore be at an even higher risk of thrombotic complications. Here, we discuss a postpartum patient with COVID-19 who developed an isolated splenic infarction. While describing a rare thrombotic event, this case serves to alert physicians to the higher risk of thrombosis in pregnant or postpartum patients with COVID-19. A previously healthy 27-year-old female who was 37 weeks pregnant, with no past medical history presented to the hospital with complaints of fever, cough, and shortness of breath. She tested positive for COVID-19 and as she was improving, was discharged home. She presented to the hospital again 2 days later with worsening fevers and tachypnea and was transferred to our hospital for further management the same day. On day 2 of admission, she vaginally delivered a healthy baby girl. She continued to have worsening tachypnea and increasing oxygen requirements postpartum, eventually requiring endotracheal intubation on day 8. She was proned on the following day for refractory hypoxia with improvement in respiratory parameters. One dose of convalescent plasma (200 mL) was given on day 4 of admission and an 800 mg dose of tocilizumab on day 9 after concomitant bacterial infection was ruled out. She was also started on prophylactic heparin 5,000 units subcutaneously three times a day 2 days after delivery and continued throughout her stay. While intubated, the patient was hemodynamically stable and required only minimal vasopressor medications probably due to sedation effect. The patient's respiratory status started improving and ventilator weaning protocols were initiated. She tolerated supination on day 14. The patient had persistent low-grade fevers post-delivery with an elevation in her white blood cell in the 12 to 20 k/µl range. Multiple blood cultures were sent that were all negative. Her markers of inflammation were elevated initially after intubation with a ferritin of 486.9 ng/mL, C-reactive protein of 44.5 mg/L, and sedimentation rate of 75 mm/h. These markers improved progressively throughout her course. She did not have any laboratory abnormalities suggesting a hypercoagulable state with an initial fibrinogen of 368 mg/dL that stayed in the normal range throughout her stay. Prothrombin time, activated prothrombin time, and platelet count were also normal on admission and during her hospitalization. Her kidney function was also normal throughout in the 0.36 to 1.07 mg/dL range. Her D-dimer was elevated to >20 µg/mL immediately post-delivery but then decreased to 8.2 µg/mL a few days later. Her D-dimer level then gradually increased again, peaking at >20 µg/mL. On day 21, she complained of abdominal pain. In the setting of persistent fever and leukocytosis, there was concern for an abscess or intraabdominal catastrophe related to her delivery, such as, but not limited to, colonic pseudo-obstruction, infection, uterine involution, or foreign body retention. A computed tomography (CT) scan of the abdomen was therefore obtained that revealed multiple new hypodense splenic infarcts with possible prior hemorrhage into one infarct ([Figs. 1], [2]). There were no thromboembolic or infarctions noted on a prior CT chest and abdomen done earlier in the admission. Echocardiogram did not reveal any cardiac thrombi or vegetations that along with the negative blood cultures argued against embolic phenomena. The patient was started on therapeutic dose low molecular weight heparin (LMWH). She was successfully extubated on day 23 and was transitioned to apixaban prior to discharge. She is currently doing well. Patients with COVID-19 are predisposed to thrombotic complications with cases of pulmonary embolism, deep vein thrombosis, and ischemic strokes reported.[1] The incidence of thrombotic complications is ∼31% in critically ill patients with COVID-19.[2] These complications are thought to be due to the presence of a hypercoagulable state from vascular damage in the setting of sepsis, from the virus itself, and from prolonged immobilization.[3] Abdominal visceral infarctions have been reported in COVID-19. We found only two case series with four patients in total who had splenic infarctions. Most of the cases had associated thrombosis of the intestines, kidney, or pulmonary vasculature and only two cases of isolated splenic infarction were reported.[4] [5] [6] Pregnancy is a known prothrombotic state as there is an elevation of procoagulant factors like factors II, VII, VIII, XII, and a reduction in anticoagulant factors such as protein S. There is also reduction in fibrinolysis due to increased activity of fibrinolytic inhibitors. These changes tend to persist up to 8 weeks after delivery.[7] Splenic infarcts are not a common complication in pregnancy unless the patient has associated conditions like infective endocarditis.[8] Other potential causes of splenic infarction include malignancy, vasculitis, and red blood cell disorders like sickle cell disease.[9] Our patient was relatively healthy and did not have a history of obesity, malignancy, autoimmune disorders or vasculitis, atrial fibrillation, and no red blood cell abnormalities were noted on peripheral smear. There was also no personal or family history of hypercoagulability. Patients with splenic infarctions have a varied presentation with fever and left upper quadrant abdominal pain being the most common. Patients may also have left sided chest pain, pleural effusion, hiccups due to diaphragmatic irritation, and abdominal distention. Ultrasound or CT of the abdomen can help with the diagnosis; however, a CT scan is preferred as it provides more information on adjoining organs and blood vessels. The management for splenic infarction involves treatment of the underlying disease state along with...

15 September 2022 in Cureus
Verified
Journal Article
Open access
JAJanani Arunachalam
Janani Arunachalam
HRHaripriya Radhakrishnan
Haripriya Radhakrishnan
HPHarsh Patel
Harsh Patel
GJGurleen K. Johal
Gurleen K. Johal
GMGnana Deepthi Medarametla
Gnana Deepthi Medarametla
NCNisarg Changawala
Nisarg Changawala
Inflammatory myofibroblastic tumors (IMTs) are a group of soft tissue neoplasms with a predilection for the lungs and abdominopelvic cavity, characterized by a mixture of fasciitis-like, compact spindle cells, hypocellular fibrous histologic patterns, and distinctive molecular features. Due to their unspecified symptoms and non-specific radiologic presentation, the histopathologic and immunohistochemical analysis of a biopsy specimen is crucial for the diagnosis. We present a case of a 30-year-old man with intermittent hemoptysis diagnosed with a pulmonary IMT. We aim to review the literature regarding its definition, clinical findings, diagnosis, treatment, and prognosis. The treatment for an IMT is based on its location and extent, including complete surgical resection, which has a good prognosis compared to corticosteroids, chemotherapy, radiotherapy, and non-steroidal immunomodulation in patients who are not good surgical candidates. Further investigative studies with larger sample sizes and longer meticulous follow-ups are needed to demonstrate this neoplastic disease's natural history and find appropriate management for it.

29 July 2020 in Infectious Diseases
Verified
Journal Article
Closed access
SMSyed Nazeer Mahmood
Syed Nazeer Mahmood
CWChristian J. Woods
Christian J. Woods
CCChee Man Chan
Chee Man Chan
(2020). COVID-19: associated morbidity and mitigation strategies. Infectious Diseases. Ahead of Print.

1 May 2023
Verified
Conference Paper
Closed access
ARA. Raheem
A. Raheem
SSS.A. Selvam
S.A. Selvam
SMSyed Nazeer Mahmood
Syed Nazeer Mahmood
UPU.K. Patel
U.K. Patel
PKP. Kamani
P. Kamani
FMF.A. Malik
F.A. Malik